The global kidney dialysis market is anticipated to grow at a CAGR of around 5.7% from 2020 to 2027 and expected to reach the market value of around US$ 96.5 Bn by 2027.
Kidney dialysis is a procedure to remove waste products and excess fluid from the blood when the kidneys stop functioning. If kidneys are not functioning properly due to advanced chronic kidney disease (CKD) the kidneys are unable to clean the blood properly. Waste products and fluids can build dangerous levels in the body. If left untreated, it can cause a number of unpleasant symptoms and eventually be fatal. As per the statistics revealed by the Centers for Disease Control and Prevention (CDC), CKD is more common in people aged 65 years or older (38%) than in people aged 45-64 years (13%) or 18-44 years (7%). Furthermore, CKD is the 9th leading cause of death in the US. In 2017, over 500,000 patients received dialysis treatment, and over 200,000 lived with a kidney transplant according to the estimates released by the National Kidney Foundation Inc. Additionally, 746,557 Americans in 2017 had kidney failure and needed dialysis to survive. Apart from that, in end-stage kidney disease (ESKD) nearly 125,000 people started ESKD treatment out of that 120,834 started dialysis as a treatment option to survive.
One of the major factors driving the global kidney dialysis market is the rising prevalence of kidney diseases. The World Health Organization (WHO) estimates that about 1.7 million people die every year as a result of acute kidney injury. As a result, an estimated 5-10 million people die every year as a result of kidney disease. However, the total number of people undergoing dialysis because of kidney failure has steadily increased from 19 million in 1990 to 33 million in 2013. According to the Kidney Care UK estimates almost 30,000 people in the UK are on dialysis for treatment of acute kidney injury.
Government funding or initiative, on the other hand, fuels the market for dialysis treatment for patients with kidney failure. The Centers for Medicare & Medicaid Services (CMS) announced that the end-stage renal disease (ESRD) as a treatment option (ETC) Model has been finalized in order to increase or sustain the standard of care for patients with CKD by lowering expenditures. President Trump's Advancing Kidney Health Executive Order encouraged greater use of home dialysis and kidney transplantation to enhance the quality of life of Medicare beneficiaries with ESRD, and the ETC Model supports such initiative. The ETC Model will represent nearly 30% of kidney care providers and will go into effect on January 1, 2021, with a savings estimate of US$ 23 million over five and a half years.
Kidney dialysis market is segmented based on product, application, and end-user. Based on product, it is segmented as hemodialysis (HD) equipment, peritoneal dialysis (PD) equipment, concentrates & solutions, catheters & tubing, and others. By application, the market is bifurcated as hemodialysis and peritoneal dialysis. Furthermore, end-user is classified into in-center dialysis settings and home care settings.
Hemodialysis (HD) equipment will dominate the overall kidney dialysis market under product segment. One of the major factors driving the growth of the hemodialysis (HD) equipment segment that contributes to the global kidney dialysis market is the rising prevalence of terminal kidney failure among patients.
North America dominates the kidney dialysis market
Canada and the United States are predicted to dominate North America during the forecast period. Increase in adoption of new technologies that pinpoint kidney dialysis equipment, as well as the presence of a large pool of prominent players and the launch of new hemodialysis and peritoneal dialysis devices with various interventions, all has a positive impact on the global kidney dialysis market's growth. Furthermore, the growth of the kidney dialysis market is fueled by growing public healthcare expenditure and increased awareness about available kidney treatment options. DaVita Healthcare Partners, Inc., Baxter International, Inc., Rockwell Medical, Inc., Becton, Dickinson and Company, Isopure Corp. are key players residing in the North America province highly involved in launching new products for dialysis to treat kidney disease.
On the other hand, Baxter International Inc. announced collaboration with Ayogo Health Inc. The collaboration launches pilot of “CKD&Me” in several nephrology practices across the United States. The two companies partner to build “CKD&Me”, a unique app for smartphones and tablets that tailors its educational content to chronic kidney disease (CKD) patients’ individual learning needs. Kidney disease is associated with a tremendous economic burden. High income countries typically spend more than 2-3% of their annual health care budget on the treatment of end-stage kidney disease, even though receiving such treatment represents under 0.03% of the total population.
In 2010, 2.62 million people received dialysis worldwide and the need for dialysis is projected to double by 2030 as per the World Health Organization (WHO). Additionally, in 2015, in the US Medicare expenditure on chronic and end-stage kidney disease was more than US$64 Bn respectively. Furthermore, according to a study released by the US Department of Health and Human Services (HHS), HHS is putting more emphasis on developing better capabilities to detect kidney disease early in high-risk patients and supporting new research to discover clinically useful biomarkers for better CKD detection. The CDC develops and maintains the national CKD surveillance system, which is the only interactive and detailed collection of CKD-related data in the United States that aids in monitoring performance toward national Healthy People goals. CDC continues to improve understanding of kidney prevalence, risk factors, and health consequences by investing in the CKD surveillance system and conducting innovative epidemiological research.
Asia Pacific will register significant CAGR in the forecast period
The extreme growing number of patients with end-stage renal disease, Asia-Pacific is projected to rise the quickest. This region is expected to see substantial growth in the number of kidney dialysis patients, resulting in overall market growth. According to the Saudi Journal of Kidney Diseases and Transplantation, as India's population grows beyond one billion, it is expected to become a major source of chronic diseases such as diabetes and hypertension. Since 25% of these people will develop CKD, the burden of end-stage renal disease (ESRD) will rise, and the healthcare system will have to deal with it.
The prominent players involved in the global kidney dialysis market involve Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, B. Braun, Becton, Dickinson and Company, Nipro Corporation, Medtronic plc, Nikkiso Co., Ltd., Asahi Kasei Medical Co., Ltd, Cantel Medical Corporation, and among others
Market By Product
Hemodialysis (HD) Equipment
Peritoneal Dialysis (PD) Equipment
Concentrates & Solutions
Catheters & Tubings
Market By Application
Market By End-User
In-Center Dialysis Settings
Home Care Settings
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Kidney dialysis market is expected to reach a market value of around US$ 96.5 Bn by 2027.
The kidney dialysis market is expected to grow at a CAGR of around 5.7% from 2020 to 2027.
Based on product, hemodialysis (HD) equipment segment is the leading segment in the overall market.
Rising prevalence of kidney disorder is one of the prominent factors that drive the demand for kidney dialysis market.
Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, B. Braun, Becton, Dickinson and Company, Nipro Corporation, Medtronic plc, Nikkiso Co., Ltd., Asahi Kasei Medical Co., Ltd, Cantel Medical Corporation, and among others.
North America is anticipated to grab the highest market share in the regional market
Asia Pacific is expected to be the fastest growing market in the forthcoming years